Stationary motorized cycling assisted by functional electrical stimulation (FES) is a popular therapy for people with movement impairments. Maximizing volitional contributions from the rider of the cycle can lead to long-term benefits like increased muscular strength and cardiovascular endurance. This paper develops a combined motor and FES control system that tasks the rider with maintaining their cadence near a target point using their own volition, while assistance or resistance is applied gradually as their cadence approaches the lower or upper boundary, respectively, of a user-defined safe range. Safety-ensuring barrier functions are used to guarantee that the rider's cadence is constrained to the safe range, while minimal assistance is provided within the range to maximize effort by the rider. FES stimulation is applied before electric motor assistance to further increase power output from the rider. To account for uncertain dynamics, barrier function methods are combined with robust control tools from Lyapunov theory to develop controllers that guarantee safety in the worst-case. Because of the intermittent nature of FES stimulation, the closed-loop system is modeled as a hybrid system to certify that the set of states for which the cadence is in the safe range is asymptotically stable. The performance of the developed control method is demonstrated experimentally on five participants. The barrier function controller constrained the riders' cadence in a range of 50 ± 5 RPM with an average cadence standard deviation of 1.4 RPM for a protocol where cadence with minimal variance was prioritized and used minimal assistance from the motor (4.1% of trial duration) in a separate protocol where power output from the rider was prioritized.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652117 | PMC |
http://dx.doi.org/10.3389/frobt.2021.742986 | DOI Listing |
J Mol Model
January 2025
School of National Defense & Nuclear Science and Technology, Southwest University of Science and Technology, Mianyang, 621010, People's Republic of China.
To clarify the effect of heating rate on the thermal decomposition process of 1,3,5-triamino-2,4,6-trinitrobenzene (TATB), this study employs molecular dynamic simulations to investigate the thermal decomposition of TATB at heating rates of 20, 40, 60, and 80 K/ps. The initial temperature is uniformly set to 300 K, while the final temperature is set to 3000 K. Results indicate that within the temperature range of 300-3000 K, the thermal decomposition rate of TATB decreases with increasing heating rate, whereas the initial decomposition temperature of TATB increases, consistent with the experimental pattern.
View Article and Find Full Text PDFCureus
December 2024
Clinical Pharmacology, Botanic Tonics, LLC, Calabasas, USA.
This study investigates the safety of three different daily dosages of a liquid blend containing kava and kratom (Feel Free® Classic Tonic {FFCT}) in healthy adults over six consecutive days of supplementation. Both kava and kratom have been used traditionally for hundreds of years, but there is limited data on the combined safety of these ingredients. In this randomized, double-blind, placebo-controlled trial, the participants were assigned to receive one of three daily dosages of FFCT or placebo.
View Article and Find Full Text PDFJ Dent Sci
December 2024
Faculty of Dentistry, The University of Hong Kong, Hong Kong, S.A.R., China.
The World Health Organization (WHO) has added glass ionomer cement (GIC) to the WHO Model List of Essential Medicines since 2021, which represents the most efficacious, safe and cost-effective medicines for priority conditions. With the potential increase in the use of GIC, this review aims to provide an overview of the clinical application of GIC with updated evidence in restorative and preventive dentistry. GIC is a versatile dental material that has a wide range of clinical applications, particularly in restorative and preventive dentistry.
View Article and Find Full Text PDFEndoscopic injection sclerotherapy (EIS) is a useful prophylactic hemostatic procedure for esophageal varices. However, injecting sclerosing agents into blood vessels is technically challenging and often ineffective. Gel-immersion EIS (GI-EIS) may facilitate easier intravascular sclerosing agent injection by dilating the varices and enhancing scope stability by maintaining low intra-gastrointestinal pressure.
View Article and Find Full Text PDFMed Chem
January 2025
São Paulo State University - UNESP, School of Pharmaceutical Sciences, Araraquara, São Paulo, Brazil.
Introduction: Epilepsy encompasses numerous syndromes characterized by spontaneous, intermittent, and abnormal electrical activity in the brain. Affecting about 1-2% of the population, it is estimated that approximately 30-40% of patients experience refractory epilepsy, which does not respond to traditional anticonvulsant drugs.
Aims: Therefore, developing novel, safe, and effective antiepileptic drugs remains a medical need.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!